Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Impedimed Ltd

IPD
Current price
0.054 AUD -0.001 AUD (-1.82%)
Last closed 0.055 AUD
ISIN AU000000IPD8
Sector Healthcare
Industry Medical Devices
Exchange Australian Securities Exchange
Capitalization 115 199 752 AUD
Yield for 12 month -60.00 %
1Y
3Y
5Y
10Y
15Y
IPD
21.11.2021 - 28.11.2021

ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California. Address: 5900 Pasteur Ct., Carlsbad, CA, United States, 92008

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.22 AUD

P/E ratio

Dividend Yield

Current Year

+10 490 231 AUD

Last Year

+11 532 239 AUD

Current Quarter

+5 626 847 AUD

Last Quarter

+4 863 384 AUD

Current Year

-14 207 914 AUD

Last Year

-13 880 571 AUD

Current Quarter

+4 933 529 AUD

Last Quarter

-7 958 912 AUD

Key Figures IPD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -23 845 223 AUD
Operating Margin TTM -200.92 %
PE Ratio
Return On Assets TTM -25.97 %
PEG Ratio
Return On Equity TTM -38.95 %
Wall Street Target Price 0.22 AUD
Revenue TTM 10 490 231 AUD
Book Value 0.02 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.7 %
Dividend Yield
Gross Profit TTM 9 960 585 AUD
Earnings per share -0.01 AUD
Diluted Eps TTM -0.01 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -191.78 %

Dividend Analytics IPD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IPD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 368:355
Payout Ratio
Last Split Date 03.04.2020
Dividend Date

Stock Valuation IPD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 9.3382
Price Sales TTM 10.9816
Enterprise Value EBITDA -9.3366
Price Book MRQ 2.8806

Financials IPD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IPD

For 52 weeks

0.043 AUD 0.16 AUD
50 Day MA 0.056 AUD
Shares Short Prior Month
200 Day MA 0.074 AUD
Short Ratio
Shares Short
Short Percent